title: p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.
abstract: OBJECTIVE
  Indoxyl sulfate and p-cresyl sulfate are important protein-bound uremic retention solutes whose levels can be partially reduced by renal replacement therapy. These solutes originate from intestinal bacterial protein fermentation and are associated with cardiovascular outcomes and chronic kidney disease progression. The aims of this study were to investigate the levels of indoxyl sulfate and p-cresyl sulfate as well as the effect of probiotics on reducing the levels of uremic toxins in pediatric patients on dialysis.
  
  
  METHODS
  We enrolled 20 pediatric patients undergoing chronic dialysis; 16 patients completed the study. The patients underwent a 12-week regimen of VSL#3, a high-concentration probiotic preparation, and the serum levels of indoxyl sulfate and p-cresyl sulfate were measured before treatment and at 4, 8, and 12 weeks after the regimen by using fluorescence liquid chromatography. To assess the normal range of indoxyl sulfate and p-cresyl sulfate we enrolled the 16 children with normal glomerular filtration rate who had visited an outpatient clinic for asymptomatic microscopic hematuria that had been detected by a school screening in August 2011.
  
  
  RESULTS
  The baseline serum levels of indoxyl sulfate and p-cresyl sulfate in the patients on chronic dialysis were significantly higher than those in the children with microscopic hematuria. The baseline serum levels of p-cresyl sulfate in the peritoneal dialysis group were significantly higher than those in the hemodialysis group. There were no significant changes in the levels of these uremic solutes after 12-week VSL#3 treatment in the patients on chronic dialysis.
  
  
  CONCLUSIONS
  The levels of the uremic toxins p-cresyl sulfate and indoxyl sulfate are highly elevated in pediatric patients on dialysis, but there was no significant effect by probiotics on the reduction of uremic toxins in pediatric dialysis patients. Therefore, studies for other medical intervention to reduce uremic toxins are also necessary in pediatric patients on dialysis.
authors: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
authors: Hye Sun
authors: HS
authors: Hyun
authors: Kyung Hoon
authors: KH
authors: Paik
authors: Hee Yeon
authors: HY
authors: Cho
keywords: Children; Chronic dialysis; Indoxyl sulfate; Probiotics; p-Cresyl sulfate
references: Clin J Am Soc Nephrol. 2009 Dec;4(12):1932-8
references: 19833905
references: Int J Food Microbiol. 2003 Mar 25;81(3):203-9
references: 12485746
references: Nephrol Dial Transplant. 2010 Nov;25(11):3693-700
references: 20466687
references: Am J Kidney Dis. 2004 Aug;44(2):278-85
references: 15264186
references: Am J Kidney Dis. 2002 Aug;40(2):339-47
references: 12148107
references: Toxins (Basel). 2011 Jul;3(7):911-9
references: 22069747
references: New Microbiol. 2001 Jan;24(1):23-33
references: 11209840
references: Kidney Int Suppl. 2009 Dec;(114):S12-9
references: 19946322
references: Clin J Am Soc Nephrol. 2008 Jan;3(1):85-90
references: 18045861
references: Nephrol Dial Transplant. 2011 Mar;26(3):1094-8
references: 20929916
references: Semin Dial. 2009 Jul-Aug;22(4):334-9
references: 19708977
references: Kidney Int. 2003 Dec;64(6):2238-43
references: 14633148
references: Am J Kidney Dis. 2008 May;51(5):839-50
references: 18436096
references: J Chromatogr A. 2009 May 29;1216(22):4684-8
references: 19394619
references: Nephron. 1996;74(2):349-55
references: 8893154
references: Am J Kidney Dis. 2005 Sep;46(3):512-9
references: 16129214
references: Kidney Int. 2003 May;63(5):1934-43
references: 12675874
references: Curr Med Res Opin. 2009 Aug;25(8):1919-30
references: 19558344
references: N Engl J Med. 2007 Sep 27;357(13):1316-25
references: 17898101
references: Kidney Int. 2006 Aug;70(4):794-9
references: 16820785
references: J Am Soc Nephrol. 1999 Aug;10(8):1815-23
references: 10446951